Lipella Pharmaceuticals Files 2024 10-K
Ticker: LIPO · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1347242
| Field | Detail |
|---|---|
| Company | Lipella Pharmaceuticals Inc. (LIPO) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, financials
TL;DR
Lipella Pharma 2024 10-K filed. Financials out.
AI Summary
Lipella Pharmaceuticals Inc. filed its 2024 10-K on March 28, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, based in Pittsburgh, PA, operates in the pharmaceutical preparations sector. Key financial figures and details about its preferred stock and grant revenues are included in the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Lipella Pharmaceuticals' financial health and operational status for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Lipella faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 5016264 — Total Assets (Represents the company's total assets as of December 31, 2024.)
- 4618965 — Total Liabilities (Represents the company's total liabilities as of December 31, 2024.)
- 15340107 — Total Equity (Represents the company's total equity as of December 31, 2024.)
Key Players & Entities
- Lipella Pharmaceuticals Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end for the reported period
- 20250328 (date) — Filing date of the 10-K
- Pittsburgh, PA (location) — Company's business and mailing address
- PHARMACEUTICAL PREPARATIONS [2834] (industry) — Company's Standard Industrial Classification
FAQ
What were Lipella Pharmaceuticals' grant revenues for the fiscal year 2024?
The filing indicates grant revenues for the period from 2024-01-01 to 2024-12-31.
What is the company's SIC code?
The company's Standard Industrial Classification code is PHARMACEUTICAL PREPARATIONS [2834].
When was the 10-K filing submitted?
The 10-K filing was submitted on March 28, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What are the reported total assets for the fiscal year ending December 31, 2024?
The total assets reported for the fiscal year ending December 31, 2024, are $5,016,264.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding LIPELLA PHARMACEUTICALS INC. (LIPO).